{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:44:32Z","timestamp":1789897472191,"version":"4.0.1"},"reference-count":117,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["theclinics.com","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cld.2015.01.012","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T08:33:13Z","timestamp":1426149193000},"page":"361-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"19","author":[{"given":"Mazen","family":"Noureddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Rinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib2","first-page":"219","article-title":"Controversies in the diagnosis and management of NAFLD and NASH","volume":"10","author":"Rinella","year":"2014","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"9","key":"10.1016\/j.cld.2015.01.012_bib3","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease: a clinical histopathological study","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2015.01.012_bib4","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1016\/j.cld.2015.01.012_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.gastro.2004.09.010","article-title":"Introduction: the burden of hepatocellular carcinoma","volume":"127","author":"Seefe","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib6","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2015.01.012_bib7","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/ajg.2013.160","article-title":"Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"108","author":"Welzel","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"17","key":"10.1016\/j.cld.2015.01.012_bib8","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0959-8049(94)90254-2","article-title":"Obesity and cancer risk: a Danish record-linkage study","volume":"30A","author":"Moller","year":"1994","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008995217664","article-title":"A\u00a0prospective study of obesity and cancer risk (Sweden)","volume":"12","author":"Wolk","year":"2001","journal-title":"Cancer Causes Control"},{"issue":"21","key":"10.1016\/j.cld.2015.01.012_bib11","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1200\/JCO.2005.11.726","article-title":"Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study","volume":"23","author":"Oh","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.cld.2015.01.012_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6603932","article-title":"Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies","volume":"97","author":"Larsson","year":"2007","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gut.2008.164053","article-title":"Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH","volume":"58","author":"Ohki","year":"2009","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of nonalcoholic fatty liver disease: a global perspective","volume":"28","author":"Lazo","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"20","key":"10.1016\/j.cld.2015.01.012_bib15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/88.20.1472","article-title":"Excess risk of primary liver cancer in patients with diabetes mellitus","volume":"88","author":"Adami","year":"1996","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.cld.2015.01.012_bib17","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","article-title":"Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark","volume":"89","author":"Wideroff","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.cld.2015.01.012_bib18","doi-asserted-by":"crossref","first-page":"e27326","DOI":"10.1371\/journal.pone.0027326","article-title":"The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1499-3872(11)60059-3","article-title":"Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis","volume":"10","author":"Wang","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib20","doi-asserted-by":"crossref","first-page":"e95485","DOI":"10.1371\/journal.pone.0095485","article-title":"Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib22","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/jhep.2002.33324","article-title":"Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis","volume":"35","author":"Ratziu","year":"2002","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.cld.2015.01.012_bib23","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1002\/cncr.24687","article-title":"Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link","volume":"115","author":"Siegel","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2015.01.012_bib27","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","article-title":"Population-based risk factors and resource utilization for HCC: US perspective","volume":"26","author":"Sanyal","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib28","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib29","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study","volume":"54","author":"Bhala","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1440-1827.2001.01174.x","article-title":"Hepatocellular carcinoma arising in non-alcoholic steatohepatitis","volume":"51","author":"Zen","year":"2001","journal-title":"Pathol Int"},{"issue":"1\u20132","key":"10.1016\/j.cld.2015.01.012_bib31","first-page":"195","article-title":"Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus","volume":"33","author":"Orikasa","year":"2001","journal-title":"J\u00a0Submicrosc Cytol Pathol"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0399-8320(04)94971-8","article-title":"Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis","volume":"28","author":"Bencheqroun","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2004.05.008","article-title":"Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma","volume":"41","author":"Bullock","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2004-860870","article-title":"Obesity as a risk factor for hepatocellular carcinoma in a noncirrhotic patient","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1381\/0960892053576596","article-title":"Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma","volume":"15","author":"Cuadrado","year":"2005","journal-title":"Obes Surg"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib36","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00428-005-0042-z","article-title":"Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid","volume":"447","author":"Sato","year":"2005","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00595-005-3167-4","article-title":"Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases","volume":"36","author":"Hai","year":"2006","journal-title":"Surg Today"},{"issue":"12","key":"10.1016\/j.cld.2015.01.012_bib38","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1440-1746.2006.04282.x","article-title":"Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis","volume":"21","author":"Ichikawa","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2015.01.012_bib39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/MEG.0b013e3282748ef2","article-title":"Primary liver cancers with nonalcoholic steatohepatitis","volume":"19","author":"Hashizume","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2015.01.012_bib40","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.5858\/132.11.1761","article-title":"Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?","volume":"132","author":"Guzman","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.cld.2015.01.012_bib41","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1590\/S0100-879X2009005000019","article-title":"Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?","volume":"42","author":"Chagas","year":"2009","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2015.01.012_bib43","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00535-009-0112-0","article-title":"Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis","volume":"44","author":"Kawada","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"issue":"Suppl 19","key":"10.1016\/j.cld.2015.01.012_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00535-008-2262-x","article-title":"Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"44","author":"Hashimoto","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2015.01.012_bib45","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3748\/wjg.v16.i12.1436","article-title":"Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review","volume":"16","author":"Takuma","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2015.01.012_bib46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s00535-010-0237-1","article-title":"Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C","volume":"45","author":"Tokushige","year":"2010","journal-title":"J\u00a0Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib47","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","article-title":"Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"9","author":"Yasui","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2015.01.012_bib48","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s11605-011-1540-8","article-title":"Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease","volume":"15","author":"Wakai","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/PAT.0b013e32834274ec","article-title":"Hepatocellular carcinomas can develop in simple fatty livers in the setting of oxidative stress","volume":"43","author":"Ikura","year":"2011","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1872-034X.2011.00915.x","article-title":"Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients","volume":"42","author":"Arase","year":"2012","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib51","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cgh.2014.08.013","article-title":"Temporal trends of non-alcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population","volume":"13","author":"Mittal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2015.01.012_bib52","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"Ertle","year":"2011","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.cld.2015.01.012_bib53","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.mcg.0000190774.91875.d2","article-title":"Liver disease in patients with diabetes mellitus","volume":"40","author":"Harrison","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2337\/diacare.24.5.843","article-title":"Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris prospective study","volume":"24","author":"Balkau","year":"2001","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib57","first-page":"89","article-title":"Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts","volume":"7","author":"Moore","year":"1998","journal-title":"Eur J Cancer Prev"},{"issue":"46 Suppl","key":"10.1016\/j.cld.2015.01.012_bib58","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1507\/endocrj.46.Suppl_S25","article-title":"The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family","author":"Kaburagi","year":"1999","journal-title":"Endocr J"},{"issue":"16","key":"10.1016\/j.cld.2015.01.012_bib59","first-page":"3831","article-title":"Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product","volume":"56","author":"Kim","year":"1996","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib60","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/hep.510260310","article-title":"Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes","volume":"26","author":"Tanaka","year":"1997","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.cld.2015.01.012_bib61","first-page":"3391","article-title":"Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis","volume":"56","author":"Tanaka","year":"1996","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/gut.51.1.100","article-title":"Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma","volume":"51","author":"Saito","year":"2002","journal-title":"Gut"},{"issue":"37","key":"10.1016\/j.cld.2015.01.012_bib63","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.3748\/wjg.v16.i37.4627","article-title":"PTEN in liver diseases and cancer","volume":"16","author":"Peyrou","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib64","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","article-title":"Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease","volume":"134","author":"Puri","year":"2008","journal-title":"Gastroenterology"},{"issue":"6913","key":"10.1016\/j.cld.2015.01.012_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A\u00a0central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jhep.2008.07.037","article-title":"Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer","volume":"50","author":"Chang","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2015.01.012_bib67","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1172\/JCI37156","article-title":"Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation","volume":"118","author":"Hui","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hep.20999","article-title":"JNK1 but not JNK2 promotes the development of steatohepatitis in mice","volume":"43","author":"Schattenberg","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib69","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/hep.23239","article-title":"Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial","volume":"50","author":"Abdelmalek","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib70","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1053\/j.gastro.2011.02.007","article-title":"JNK signaling promotes intestinal tumorigenesis through activation of mTOR complex 1 in Apc(Delta716) mice","volume":"140","author":"Fujishita","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12032-009-9201-4","article-title":"The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma","volume":"27","author":"Zhou","year":"2010","journal-title":"Med Oncol"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib72","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.24553","article-title":"Dysregulation of the unfolded protein response in db\/db mice with diet-induced steatohepatitis","volume":"54","author":"Rinella","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib73","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-0033-1358522","article-title":"The unfolded protein response in fatty liver disease","volume":"33","author":"Henkel","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib74","first-page":"1749","article-title":"Cross-talk between PI3K\/Akt and MEK\/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells","volume":"34","author":"Dai","year":"2009","journal-title":"Int J Oncol"},{"issue":"5695","key":"10.1016\/j.cld.2015.01.012_bib75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.cld.2015.01.012_bib76","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1172\/JCI26373","article-title":"Endoplasmic reticulum stress: cell life and death decisions","volume":"115","author":"Xu","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.cld.2015.01.012_bib77","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1210\/en.2004-0478","article-title":"Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress","volume":"145","author":"Kharroubi","year":"2004","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.cld.2015.01.012_bib78","first-page":"4683","article-title":"The paradox of the unfolded protein response in cancer","volume":"33","author":"Vandewynckel","year":"2013","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib79","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0168-8278(03)00029-1","article-title":"Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis","volume":"38","author":"Shuda","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2015.01.012_bib80","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbadis.2010.10.006","article-title":"Role of nuclear receptor SHP in metabolism and cancer","volume":"1812","author":"Zhang","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"7007","key":"10.1016\/j.cld.2015.01.012_bib81","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-kappaB functions as a tumour promoter in inflammation-associated cancer","volume":"431","author":"Pikarsky","year":"2004","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cld.2015.01.012_bib82","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/carcin\/23.11.1781","article-title":"The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma","volume":"23","author":"Hu","year":"2002","journal-title":"Carcinogenesis"},{"issue":"15","key":"10.1016\/j.cld.2015.01.012_bib83","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","article-title":"Regulation of the G2\/M transition by p53","volume":"20","author":"Taylor","year":"2001","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cld.2015.01.012_bib84","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0500660102","article-title":"Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia","volume":"102","author":"Xu","year":"2005","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib85","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1245\/s10434-006-9049-1","article-title":"Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma","volume":"14","author":"Maki","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib87","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.01.012_bib88","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1530\/eje.1.01859","article-title":"New insights into leptin resistance by modifying cytokine receptor signal transduction","volume":"152","author":"Dotsch","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"17","key":"10.1016\/j.cld.2015.01.012_bib89","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3748\/wjg.v10.i17.2478","article-title":"Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma","volume":"10","author":"Wang","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"Pt 1","key":"10.1016\/j.cld.2015.01.012_bib90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BJ20051578","article-title":"Intracellular signalling pathways activated by leptin","volume":"393","author":"Fruhbeck","year":"2006","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib91","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.22064","article-title":"Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta","volume":"47","author":"Ramani","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib92","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib93","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1152\/physrev.00047.2011","article-title":"S-adenosylmethionine in liver health, injury, and cancer","volume":"92","author":"Lu","year":"2012","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib94","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1665-2681(19)31355-9","article-title":"S-adenosylmethionine metabolism and liver disease","volume":"12","author":"Mato","year":"2013","journal-title":"Ann Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2015.01.012_bib95","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm1603","article-title":"Identification of a key pathway required for the sterile inflammatory response triggered by dying cells","volume":"13","author":"Chen","year":"2007","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib96","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"7285","key":"10.1016\/j.cld.2015.01.012_bib97","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib98","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib99","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.23845","article-title":"Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents","volume":"52","author":"Yu","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib101","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2015.01.012_bib102","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/pds.3685","article-title":"Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden","volume":"23","author":"Bjorkhem-Bergman","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib103","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1053\/j.gastro.2009.01.053","article-title":"Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes","volume":"136","author":"El-Serag","year":"2009","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2015.01.012_bib104","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1054\/bjoc.2000.1716","article-title":"Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial","volume":"84","author":"Kawata","year":"2001","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib105","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1158\/0008-5472.CAN-10-3367","article-title":"MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase","volume":"71","author":"Cao","year":"2011","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib106","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/ijo.2011.1273","article-title":"Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression","volume":"40","author":"Spampanato","year":"2012","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.cld.2015.01.012_bib107","first-page":"1413","article-title":"Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice","volume":"38","author":"Gao","year":"2010","journal-title":"J\u00a0Int Med Res"},{"issue":"6","key":"10.1016\/j.cld.2015.01.012_bib108","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ajg.2013.5","article-title":"Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib109","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease","volume":"30","author":"Donadon","year":"2010","journal-title":"Liver Int"},{"issue":"24","key":"10.1016\/j.cld.2015.01.012_bib110","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.3748\/wjg.v16.i24.3025","article-title":"Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma","volume":"16","author":"Donadon","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib111","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/dmrr.1291","article-title":"Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"28","author":"Wang","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib112","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1440-1746.2011.06664.x","article-title":"Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation","volume":"26","author":"Chen","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2015.01.012_bib113","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ajg.2011.384","article-title":"Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study","volume":"107","author":"Lai","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2015.01.012_bib114","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/cncr.24982","article-title":"Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma","volume":"116","author":"Hassan","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.26323","article-title":"The mTOR pathway in hepatic malignancies","volume":"58","author":"Bhat","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.01.012_bib116","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/hep.22990","article-title":"S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model","volume":"50","author":"Lu","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2015.01.012_bib117","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","article-title":"S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility","volume":"57","author":"Anstee","year":"2012","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T05:38:56Z","timestamp":1651469936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1089326115000136"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.01.012","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}